The Multidimensional Scale of Independent Functioning (MSIF) is a new instrument for rating functional disability in psychiatric outpatients. The MSIF differs from other disability rating scales by providing discrete ratings of (1) role responsibility, (2) presence and level of support, and (3) performance quality. The MSIF, which consists of a semistructured interview and detailed rating anchors, was validated in 114 psychiatric outpatients. The instrument had good criterion, discriminative, interrater, and construct validity. Correlations between comparable ratings on the Social Adjustment Scale U (SAS II) ranged from 0.78 to 0.86. Nevertheless, redundancy analysis using canonical correlation demonstrated that, although the two instruments overlap, the MSIF contains information that is not contained in the SAS IL Furthermore, there was only modest shared variance with conceptually non-overlapping subscales in the SAS IL Interrater reliability (intraclass correlation coefficients) ranged from 0.74 to 1.00 for global and subscale scores. MSIF subscales performed as expected with respect to external validators such as hours of employment, earned income, supported versus nonsupported employment and housing, and mainstream versus nonmainstream educational status. MSIF global ratings were modestly correlated with IQ and psychopathology ratings, consistent with reports in the literature. Construct validity, estimated using Cronbach's alpha coefficient, was 0.72. The MSIF is a promising new instrument designed to circumvent several limitations with existing functional outcome instruments for longitudinal studies, intervention research, and services research.
Psychiatric disorders are responsible for an estimated onequarteT of the world's disability (Murray and Lopez 19%) .
Schizophrenia and schizoaffective disorder together constitute the fifth leading cause of disability and are responsible for more years of life lived with disability than all malignancies and HTV combined (Moller et al. 1988; Murray and Lopez 1996; Harrow et al. 1997) . A considerable disability toll exists with the major affective disorders as well, which has only recently begun to receive much-warranted attention in the literature (Lee and Murray 1988; Coryell et al. 1993; Keller and Hanks 1994; Murray and Lopez 1996; Judd 1997; Judd et al. 2000; Andrews 2001 ). In schizophrenia, disability typically persists throughout the person's lifetime and has been estimated to exact a financial cost to society three to four times that of direct patient care (Fein 1958; Gunderson et al. 1975; Andrews et al. 1985; Hall et al. 1985) . Of the estimated $65 billion cost of schizophrenia in the United States, $46 billion has been attributed to lost productivity. The societal cost of lost productivity from affective disorders is similarly vast.
The substantial prevalence and cost of disability across all major diagnoses has led to renewed efforts on the part of clinicians, researchers, and policy makers to properly classify and measure it, and to clarify its causes, with the goal of alleviating and possibly preventing incapacity. In recognition of the need to examine the human and economic burden of disability, the World Health Organization has released a new system for classification of disability, the International Classification of Functioning, Disability and Health (WHO 2001) . Accurate assessment of disability is also important for long-term followup studies (e.g., genetic studies) investigating alternative systems for disease classification.
Reliable measures of independent functioning may clarify the course of serious psychiatric disorders better than symptom ratings alone. This has become particularly clear in the case of bipolar disorder, in which studies have shown that disability persists even during periods of apparent recovery (i.e., when clinical indicators are minimal or absent) (Dion et al. 1988; Coryell et al. 1993) . A similar dissociation between manifest symptomatology and disability occurs in schizophrenia, although extreme dissociations are rarer. Nevertheless, such cases may represent distinct diagnostic subgroups within the larger categories of schizophrenia and schizoaffective or bipolar disorder. Alternatively, interepisode functional recovery may prove to be a critically important feature distinguishing the diagnostic categories. Studies seeking to validate alternative phenotypes require a valid and reliable instrument for describing the severity of disability.
Independent functioning is also an important aspect of treatment outcome. Unfortunately, effective therapeutic symptom management too often fails to provide equally effective improvement in quality of independent functioning Carpenter 1972, 1978; Strauss et al. 1974; Anthony and Jansen 1984; Meltzer 1992) . Clinical investigators have called for the inclusion of disability assessment in studies evaluating the therapeutic benefit of new pharmacotherapeutic agents (e.g., Meltzer 1992; Lehman 1996; Meltzer et al. 1996) . It is necessary to investigate whether treatments that may be equivalent with respect to symptom reduction or stabilization differ significantly with respect to independent functioning over time. However, this requirement is not limited to studies of alternative pharmacotherapies; the effectiveness of targeted rehabilitative and remedial interventions must ultimately be gauged using life functioning measures as well. In addition, independent functioning measures may prove to be more useful for assessing the long-term benefit of new interventions than clinical ratings, for example, where improved independent functioning is sustained longitudinally and is associated with a reduced need for rehospitalization (because of, e.g., more effective self-care, independent of clinical symptom severity).
Measures of independent functioning may offer more sensitive indexes for evaluating the economic benefits of new treatments compared to conventional indexes of indirect illness cost such as lost wages. A rating system that incorporates the support a patient receives to maintain various community roles as well as the patient's effectiveness in carrying out these roles could be used in a pharmacoeconomic analysis to study savings realized from a reduction in the amount of support required or an increase in role effectiveness resulting from treatment Changes in the support required to maintain employment or an independent apartment (e.g., twiceweekly on-site visits versus a weekly phone call from a job coach or housing counselor) or level of actual work productivity relative to normal job expectations would constitute objectively important treatment benefits that are not captured using available instruments.
Limitations of Existing "Outcome" Instruments for Studying Disability
Rating scales for measuring the severity of psychopathology, such as the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham 1988) , the Positive and Negative Syndrome Scale (Kay et al. 1987) , the Hamilton Rating Scale for Depression (Hamilton 1960) , and the Young Mania Rating Scale (Young et al. 1978) are the most commonly used scales for assessing treatment outcome. By convention, however, the term outcome measure has come to refer to those scales designed to rate some broader aspect of illness consequence, such as social or personal activities involving self-care, social relationships, instrumental roles, or some subjective or objective index of quality of life (e.g., Ellis et al. 1984; Brekke 1992; Eisen et al. 1994; Dickerson 1997 ; Joint Commission on Accreditation of Healthcare Organizations 1998). Furthermore, because most serious psychiatric disorders are persistent and lack a defined endpoint for designating the true outcome of the illness, the term outcome refers not to any discernable illness endpoint but rather to a designated time relative to a treatment or episode onset. Dimensions under the umbrella of "outcome measure" include adaptive behavior (Clinger et al. 1988) , social behavior (Wykes and Sturt 1986) , social functioning (Dohrenwend et al. 1983 ), social adjustment (Schooler et al. 1979; Weissman et al. 1981) , social disability (Branch and Jette 1981; Wiersma et al. 1988) , and quality of life (Heinrichs et al. 1984; Lehman 1988 ). Incorporated to varying degrees within these dimensions are physical health; psychiatric symptoms and signs such as depression, anxiety, or psychotic behavior; activities of daily living such as grooming, domestic activities, money management, and transportation; and social functioning, including friendships, family relationships, appropriateness of social behaviors, leisure activities, legal and safety matters, work, and school.
Within each of the outcome dimensions described above, scales have been developed to accommodate a number of different aspects of mental health research. Different scales can be chosen based on the study purpose (e.g., phenotypic description, treatment response, pharmacoeconomic analysis), the study design (e.g., naturalistic observation or in vitro testing in a clinical laboratory [Liberman 1982; Bellack et al. 1990; Patterson et al. 2001] , cross-sectional, longitudinal studies of change, experimental or case-control comparisons, correlational studies, or survey research for determining service needs [Green and Gracely 1987] ), and the study population (e.g., adult, child, adolescent [John et al. 1987] , or elder [Lawton et al. 1982; Linn 1988 ] populations). Some scales (e.g., those reviewed by Dickerson 1997) have been designed to capture community functioning, while others have been optimized to detect improvements within institutional settings (e.g., Baker and Hall 1988; Clinger et al. 1988; Weiner 1993) . Several are self-report based on patient interview (e.g., Lehman 1988; Birchwood et al. 1990) . Others are independent ratings based on the report of an informant (e.g., Wykes and Sturt 1986) or a subject (e.g., Schooler et al. 1979) . A number of scales emphasize the importance of incorporating all available sources to arrive at some objective index of functioning, while still others are designed to capture the varying perspectives of different stakeholders.
The range of available instruments has the benefit of offering to researchers many vantage points from which to examine how psychiatric disorders and their treatment affect independent functioning. Brekke (1992) has classified independent functioning scales into two categories: multidimensional, meaning that they capture several different aspects of functioning, and global (e.g., Global Assessment Scale [Endicott et al. 1976] ), meaning that they incorporate symptoms and role functioning into a single measure. Despite the large number of available variations within the multidimensional and global scales, both types still have significant limitations for the assessment of functional disability.
One major disadvantage of global scales is that when functional disability is confounded with psychiatric symptoms, it is impossible to discern what aspect of a particular patient's illness is being measured. This is a problem for many types of studies, considering that only modest correlations have been reported between presence and severity of rated psychiatric symptoms and functional disability Carpenter 1972, 1978; Strauss et al. 1974; Anthony and Jansen 1984; Dion et al. 1988; Meltzer 1992; Coryell et al. 1993 ). This has been demonstrated to be a problem for schizophrenia studies in view of the frequently extended course of persisting psychopathology in the face of partial functional recovery. In affective disorders, on the other hand, disability may persist even after syndromal recovery. Global scales do not permit the exploration of this important dissociation between symptoms and critical aspects of independent functioning.
Multidimensional scales pose challenges as well. For instance, it has been demonstrated that instruments widely believed to measure similar constructs may overlap only partially if at all (Brekke 1992; Dickerson et al. 2000) . Nevertheless, there appears to be widespread agreement that the independent assessment of multiple dimensions of outcome functioning is necessary. The most commonly assessed content areas of multidimensional outcome scales appear to be self-care and social relationships (Wallace 1986; Dickerson 1997) . Fewer instruments are available to evaluate functional disability in major life roles such as work, school, and independent living, and those that do all share fundamental limitations in their ability to capture important changes over time. In the real world, functional improvement can take the form of greater role responsibility (i.e., more work hours, more responsibility, a bigger courseload, or a more demanding educational program); or, within an existing role, improved performance or a reduction in level of support needed. Among validated and widely used multidimensional outcome measures that evaluate functional disability in instrumental life roles, none can differentiate between patients having a similar role responsibility (e.g., a vocational activity) who may be sustaining this role with vastly differing support requirements and levels of performance success (e.g., the Social Adjustment Scale II [SAS II] [Schooler et al. 1979 ], the Role Activity Performance Scale [Good- Ellis et al. 1987] , the World Health Organization Disability Assessment Schedule [Janca et al. 1996; WHO 2000] , and the Role Functioning Scale [Goodman et al. 1993] ). None of these scales provide separate measures of (1) the individual's role responsibility, (2) the support the individual receives or requires for that role, and (3) the individual's performance in that role given the level of support. Moreover, the scales' structure makes it impossible to determine whether the difference in ratings, either between individual patients or for repeated measures of the same patient over time, is due to a difference in level of the assigned role, in performance quality, or in support. As a consequence, these scales cannot clearly discriminate, for example, between a patient sustaining a part-time job with no performance deficits in a competitive environment and a patient having a similar part-time job and maintaining adequate performance with significant formal or informal support These types of distinctions are critical for an accurate and realistic behavioral7clinical picture of the patient's independent functioning capacity.
Rationale for the Development of a New Instrument: The Multidimensional Scale of Independent Functioning For the past decade, a major aim of our research in both schizophrenia and affective disorders has been to study the role of symptoms and specific neurocognitive deficits in producing disability (or recovery from disability) during the illness course. Our studies are conducted longitudinally in the context of a large array of available rehabilitative services, including inpatient as well as ambulatory recovery services, and dedicated programs for psychiatric rehabilitation, vocational training, job placement, supported employment, supported education, client businesses, transitional employment and work enclaves, and community housing programs. It has become apparent that neither the enormous range of formal and informal sup-ports that are available to individuals recovering life roles in the community nor the range of tolerance for diminished performance levels was captured in available instruments for rating instrumental role functioning. We believe that the lack of a method for capturing these critical aspects of functional recovery in a rating instrument significantly hampered our efforts to study the contributions of symptoms and neurocognitive deficits to role functioning disability. In short, the added support available to some patients to help them sustain a community role, and circumstances in which diminished performance was tolerated without risk for role loss, represented a significant source of extraneous and unaccounted-for variability that diminished the power to detect relationships between disability and clinical risk factors for disability (e.g., symptoms, neurocognitive deficits). We further reasoned that, with respect to assessing the benefits of both rehabilitative and pharmacotherapeutic interventions for instrumental role functioning, the ability to independently rate role position, support, and performance would be critical for detecting true changes in functional ability that would be missed by alternative rating scales.
These limitations became apparent early in our work. Thus, to capture essential patient differences that were being missed by other instruments, we began to develop and test anchored ratings reflecting the independent contributions of support (both formal and informal) and the range of tolerance for poor role performance that exists in various environments. Throughout the development process, experts in rehabilitation and social services were consulted. In addition to discussions regarding our conceptual approach, the development of anchors and rating instructions was guided by expert ranking of prototypical cases with respect to the patient's level of functioning.
This work ultimately led to development of the Multidimensional Scale of Independent Functioning (MSIF), which was designed to elicit and appropriately discriminate (by providing for independent ratings) the dimensions of role responsibility, support, and performance within the work, education, and residential domains. To illustrate how these independent ratings would be critically more informative than conventional ratings, consider a patient in a treatment trial who has shown improved functional capacity, perhaps because of improved cognitive performance relative to baseline, but no change in work role position. If an instrument such as the SAS n were used, no change in the global rating for instrumental role performance would be observed. However, improved functional capacity may instead be reflected in a reduction in level of support needed for the given role and/or an increased quality of performance for that role. With the MSIF, these functional improvements would be captured. Thus, the two instruments would provide contradictory conclusions about the benefit of the new treatment with respect to independent functioning.
Methods
Description of the Scale. The MSIF provides anchors for rating independent functioning in work (which includes dependent care), education, and residential domains. Independent functioning is further broken down and anchors are provided for three dimensions: role position (RP), support (SU), and performance (PE). Global MSIF ratings within each environment are then made; these reflect the overall level of independent functioning, given how the patient spends time in the context of a range of available supports, and conditions of varying tolerance for deficiency in performance. In making a global rating, the idea is to estimate independent functioning level in a manner that, to the greatest possible degree, "corrects" for variability explained by the specific context within which the patient is functioning. The scale captures a 1-month time period but can be adapted to capture a longer period.
Use of MSIF. MSIF ratings are made by applying a set of detailed anchors to information obtained in a semistructured interview with the patient (available from the authors). External sources of information are also used when available, including interviews with family members, employers, rehabilitation and housing counselors, and clinical staff. The interview provides for a thorough analysis of the patient's day-to-day activities in each of the three environments assessed: work (e.g., competitive, supported, dependent care, volunteer), education (e.g., college, vocational or certificate school, rehabilitation training program), and residential (e.g., where the patient is living, what responsibilities the individual has). For example, when a rating is made for the work environment, the MSIF would consider not only the job title but also what work the job involves, when and at what pace tasks are completed, with what level of supervision or self-initiation tasks are performed, what assistance is received, and to what performance standard the work is held.
The information is then coded for each applicable environment on each of three dimensions according to a set of detailed anchors: RP, SU, and PE. In addition, global ratings are made within each environment (work, education, residential), within each role dimension (RP, SU, PE), and for overall independent functioning. As an example, the anchors for the work environment are shown in the appendix. The full instrument, including semistructured interview and rating anchors, is available from the authors.
Operational Definitions
RP. RP refers to the actual role the individual is expected to perform. Examples of work RP would include a full-time job or part-time volunteer work. The work RP rating reflects the level of responsibility inherent in the person's work role, including number of hours worked, whether the salary is above or below minimum wage (or the standard expected wage in the subject's setting), and whether the role is in a mainstream community environment (i.e., a program or position open to all and not "segregated" to include only disabled individuals). Residential RP ratings could include living independently in an apartment or living in a group home with responsibilities for only some activities of daily living. Residential RP ratings similarly reflect such factors as how much responsibility and independence are inherent in the role and whether the residence is in a mainstream setting.
SU. SU refers to the amount of assistance an individual receives in the specified role position or task. Assistance can range from occasional guidance in the planning or scheduling of essential activities, to direct assistance with an activity, to the complete takeover of the task or role by another person. Support may be provided by colleagues, friends, family members, or mental health professionals. The SU rating will be higher (reflecting greater support) when the support provider is a mental health professional than when it is a friend or colleague.
PE. PE refers to the quality of the productive activities compared to normal expectations within the role environment as well as their timeliness and the reliability with which they are performed.
Global. Global ratings within each environment are made by beginning with the RP rating for that environment and adjusting it according to (1) how much additional support is needed (beyond what is typical for the specific environment), and (2) performance, given the level of support. This rating reflects the global impression of level of independent functioning within that environment across role dimensions, which may not be the same as the average of the various component ratings. Global ratings within each role domain reflect the overall level of role responsibility, support, and performance across environments.
Overall global. The overall global rating across all environment categories is made the same way the global rating within each environment is made. While the individual global ratings from the three environments each contribute to the overall global rating, work is generally weighted most strongly, followed by education and residential. In young adults, where the expected role is school attendance, however, the educational role is weighted most strongly. Because this is a rating of role functioning relative to community norms across all environments, the overall global rating is designed to reflect a total level of disability relative to expected roles for that individual's peer group.
Rating Method. Each dimension (i.e., RP, SU, PE, and global) is rated along a seven-point Likert scale (1 = normal functioning; 7 = total disability). Detailed anchors are provided for all ratings. For RP and PE, anchors contain both general descriptions and specific cases that can be adapted for different research settings. The intent of such extensive anchoring is to minimize rater judgment and maximize interrater agreement.
Education is rated only if the patient is in a school, training, or educationally oriented rehabilitation program. If a patient is both working and in school, both are rated. If a patient is only working and not in school, then no rating is made for education, and vice versa.
Essential to the correct application of this scale is the understanding that each of the dimensions-RP, SU, and PE-can be rated independently within each environmental domain. For example, the MSIF easily distinguishes the following two cases: (1) an individual who works halftime in a sandwich shop owned by a parent who tolerates very poor productivity and frequent absenteeism, and (2) an individual who works in a sandwich shop in a job obtained competitively and independently who is adequately meeting performance requirements. These two cases would be rated identically on RP. However, the sharply contrasting SU and PE ratings would clearly reflect the substantial difference in the functional capacity of these two individuals. It is critically important to capture such distinctions in studies seeking to correlate functional capacity with neurocognitive or clinical factors, or studies examining the efficacy of alternative rehabilitative or psychopharmacologic interventions.
The MSIF ratings capture the modal state during a 1-month period prior to the interview. Historical data are also collected to better characterize the patient's baseline. Followup assessments allow the determination of changes in role position, level of support used, and performance success in each environment over time. These followup assessments can easily be conducted by telephone, allowing for lower-cost long-term studies of functional outcome.
Subjects. The validation sample for the MSIF consisted of 114 outpatients (65% male) who provided informed consent, ranging in age from 18 to 50 (mean = 34.2, standard deviation [SD] = 7.51). Age of illness onset averaged 20.4 years (SD = 6.5, range = 5 to 39), and most recent hospitalization was on average 4.3 years prior to study participation (SD = 3.8, range = 3 months to 17 years). Three samples were merged for the purpose of this valida-tion study. The first included 55 Hillside Hospital ambulatory clinic patients randomly selected from among cases having a schizophrenia or schizoaffective diagnosis, no active substance use, ages from 18 to 45, at least a 5-year illness duration, and less than 3 months since the most recent hospitalization. The second group comprised 28 participants in Hillside's First Episode study of psychosis. Most had been ill for at least 3 years at the time of participation in this study. Subjects in the first two samples were rated with the MSIF during their participation in a study examining the role of neurocognitive deficits in disability. Added to these existing research samples were 31 representative enrollees in one of three psychiatric rehabilitation programs operated by Hillside. This sample was added to study the utility of the MSIF in a rehabilitation setting. Diagnosis was confirmed using the Structured Clinical Interview for DSM-III-R (Williams et al. 1992) in 60 cases. In 23 cases, the DSM-III-R diagnosis was derived from the Schedule for Affective Disorders and Schizophrenia (Endicott and Spitzer 1978) . For the remaining cases (all in the rehabilitation subgroup), only chart diagnosis according to DSM-III-R was available. As shown in table 1, the sample was ethnically diverse, most subjects had at least a high school education, and nearly a quarter had education beyond high school. Various diagnostic subgroups were sampled, although the majority (71.1%) carried a schizophrenia diagnosis.
Procedures. All subjects were administered a demographic interview, the SAS n, and the MSIF. The SAS II was selected as a criterion validator because, among multidimensional instruments that provide ratings independent of symptom severity, this instrument is most widely used in treatment trials as an indicator of functional outcome. In those subjects who were participating in a larger study (n = 83), the BPRS, a comprehensive history questionnaire (including illness and treatment history as well as education, work, and residential history), and the Wechsler Adult Intelligence Scale-Revised (Wechsler 1981) were administered at the time of the SAS II and MSIF. Where ratings were not conducted by the second author, raters were clinically experienced graduate students who had been trained by the second author in the use of the instruments and had demonstrated interrater reliability against a "gold standard" on the SAS II and BPRS (intraclass correlation coefficient [ICC] > 0.80). Our training protocol for the MSIF involved reading the MSIF manual (available from the authors), attending a brief (< 1 hour) didactic presentation and discussion of the MSIF with an expert rater, observing and test-rating at least three expert-administered MSIFs, and finally undergoing expert observation of the trainee's use of the MSIF for at least three cases. For the current report, MSIF rat- ings for all subjects were reviewed by the second author.
In a handful of difficult cases, the case was reviewed by both the first and the second author as well as the interviewer (if this was not the second author). Occasionally, after an ambiguity was resolved by discussion, a new anchor was added to the existing MSIF guidelines to eliminate similar future instances of such ambiguity and the entire set of previous MSIF ratings was reviewed to ensure that the same anchors were considered for each rating.
To determine interrater reliability, 18 subjects (14 males, mean age = 33.68, SD = 6.64, range = 22-45) received independent MSIF ratings by two raters on the basis of the same interview. This cohort was selected from among the larger sample to represent the full range of levels of independent functioning. Although it would have been more in keeping with conventional standards for testing interrater reliability of a clinical rating scale if each rater had conducted an independent interview, MSIF ratings differ from traditional clinical ratings. While clinical ratings involve rater judgments, in both making ratings and extracting the information necessary to make the rating, MSIF ratings are derived by mapping to a set of detailed anchors, a set of facts obtained using a semistructured interview about daily role activities supplemented by chart reviews and all available reports from collaterals (i.e., family members, treatment providers, employers, and housing providers). Thus, differences in MSIF ratings obtained from two raters during two interviews would reflect a combination of rater difference and difference in the content and amount of information available to each rater. Because our object was to examine interrater agreement in the application of the MSIF anchors, die metiiod we adopted was deemed more appropriate. Future studies having larger samples will further explore interrater reliability and address the additional question of intrasubject agreement when obtaining information about role functioning during an interview.
Results
Sample Description. The study sample consisted of clinically stable outpatients with an average time since most recent psychiatric hospitalization of 4.3 years (SD = 3.8). Mean BPRS total score was 32.0 (SD = 9.8), suggesting a relatively mild level of psychopatbology at the time of our assessments. Mean IQ was at die low end of die average range (full-scale IQ = 91.8 [SD = 13.2], verbal IQ = 94.4 [SD = 13.0], and performance IQ = 90.1 [SD = 14.1]). On average during the past 5 years, study subjects had been engaged in voluntary or paid employment for a total of 24.5 months (SD = 28.0). At die time of the MSIF rating, 57 subjects (50% of the study sample) were active in a work role. Among tiiese, 36 were engaged in paid work, 18 were engaged in volunteer work, and 3 (1 of whom also had volunteer work) had dependent care responsibilities. Among those gainfully employed, die average hourly salary was $6.35 (SD = 3.2, range = $1.26 to $16.48); 30 received at or above minimum wage, and 6 received below minimum wage through licensed transitional employment programs. Fifty-two subjects (46% of the study sample) were engaged in some type of educational or skill development role. Of these, 19 were engaged in a "mainstream" educational program: 11 were in college, 5 were in vocational or certificate training, 1 was in adult education, and 2 were working toward a high school diploma. Five were enrolled full-time, 4 half-time, and 10 part-time. (Part time was defined as one class, less than 8 college credits, or less man 15 hours in vocational training per week.) An additional 33 subjects were engaged in some form of nonmainstream educational or rehabilitative skill development program. With respect to residential functioning, 18 (16%) of the subjects resided in a housing program (e.g., supervised community residence, supported apartment), 67 (59%) resided with one or more family members, and the remainder resided in the community without a formal support system, alone (14), widi friends (5), or with a significant other (10).
Interrater Reliability. Table 2 lists die ICCs for each rating derived from die administration of the MSIF by two raters to a selected subset of 18 subjects. There were 18 valid cases for the analysis of work ratings, and diere were 10 valid cases for education ratings: 5 patients were enrolled in an educational setting but not a work setting, 8 were enrolled in a work setting but not an educational setting, and 5 were enrolled in both a work and an education setting. All 18 cases were rated in the residential environment. ICCs for each rating made ranged from 0.74 to 1.00. ICCs for global ratings within each environment ranged from 0.91 to 0.98. The ICC for the overall global rating was 0.90. External Validity. As expected, work RP ratings on the MSIF were significantly higher (mean = 4.17, SD = 0.92), reflecting lower functional level for the 24 subjects working in jobs earning below minimum wage or holding volunteer positions, compared with those earning above minimum wage {n -30, mean = 1.63, SD = 0.81) (f = 10.78, p < 0.001, 95% confidence interval about the group mean difference [CI] = 2.06 to 3.00). As shown by correlation analyses among those gainfully employed, a better RP rating was significantly associated with a higher hourly salary (r = -0.61, p < 0.001) and more hours worked per week (r = -0.74, p < 0.001). Including those engaged in either paid or volunteer work, subjects working 25 or more hours per week received significantly better work RP ratings (n -20, mean = 1.35, SD = 0.81) than subjects working between 15 and 24 hours (n -13, mean = 2.77, SD = 1.24) (r = -3.99, p < 0.001, CI = -2.14 to -0.69) and those working less than 15 hours (/i = 22, mean = 4.00, SD = 0.98) (t = -9.50, p < 0.001, CI = -3.21 to -2.09). Similarly, those working between 15 and 24 hours received significantly better ratings on work RP than those working less than 15 hours (f = 3.26, p = 0.003, CI = -2.00 to 0.46). With respect to the work SU ratings, subjects receiving no professional support (n = 31) scored significantly better (mean = 1.26, SD = 0.77) than those receiving professional support through a transitional or supported employment program (n -24, mean = 3.21, SD = 1.28) (r = 6.57, p < 0.001, CI = -2.55 to -1.35). Thus, work RP and SU ratings discriminated critical differences in vocational functioning in the direction and manner that was expected. No external measure of work performance was available against which to vahdate the work PE rating.
With respect to education RP, subjects enrolled in a mainstream college or school environment at least halftime (n = 9, mean = 2.22, SD = 1.39) were rated superior to those enrolled only part-time (n = 8, mean = 3.88, SD = 1.25, t = -2.56, p = 0.02, CI = -3.03 to -0.28). On education SU, subjects enrolled in mainstream programs were rated as superior (n = 16, mean -1.94, SD = 1.34) to those in nonmainstream programs (n = 24, mean = 3.25, SD = 1.03, t = -3.50, p = 0.001, a = -2.07 to -0.55). As with work PE, there were no external indexes of performance quality available against which to validate the education PE ratings.
Residential RP is rated on the basis of the responsibilities the patient has for maintaining his or her residential role. Thus, as would be expected, subjects living in a mainstream environment alone, with friends, or with a significant other (n = 29) were rated better on residential RP (mean = 1.97, SD = 0.98) than those living in a community residence or supported housing (n = 18, mean = 4.28, SD = 1.45,f = 5.98,p<0.001,CI = -3.11 to-1.52). We anticipated that subjects living with family (usually an adult living with his or her parents) would be a heterogeneous group. In some cases, this arrangement might be comparable to a supported residence, while in others the subject might, like many young adults, be living with parents principally for financial reasons, managing his or her own affairs and contributing to the household. In fact, residential RP ratings for this group were slightly but statistically significantly worse (n = 67, mean = 5.09, SD = 1.06) than the supported residence group's (t --2.22, p = 0.037). Contrary to our expectation, there was significantly less variability in the group living with family than in the community residence group (Levene's test for equality of variance F = 4.11, p < 0.05).
As expected, residential SU ratings for subjects residing alone, with friends, or with a significant other (n = 28, mean = 2.14, SD = 1.41) reflected less support than for those residing in supported residences (mean = 3.33, SD = 1.24, / = -2.93, p = 0.005, CI = -2.01 to -0.37). Interestingly, SU ratings for subjects residing with family (n = 63, mean = 2.48, SD = 1.45) reflected significantly less support than for those in supported residences (/ = 2.28, p = 0.02, CI = 0.11 to 1.6) and were not significantly different from SU ratings for those living alone, with friends, or with a significant other (t --1.02, p = 0.31, CI = -0.98 to 0.31). With the MSIF, support ratings are made given the role position being rated. Our anecdotal impression is that when a subject had functional difficulties in the residential environment, supported residential programs were more likely than families to respond by adding the support needed by the client to succeed in these role responsibilities. On the other hand, families were more likely than supported residences to respond to the subject's difficulties by reducing his or her role responsibilities.
Discriminant and Criterion Validity. SAS II ratings were made for each subject at the same time that the MSIF ratings were made. Table 3 presents Pearson correlation coefficients for selected SAS II global ratings and the most comparable MSIF indexes. Correlations ranged between 0.78 and 0.86 when comparing MSIF RP and overall global ratings with SAS II role performance and general adjustment ratings, suggesting that the MSIF has high criterion validity relative to the SAS II.
With respect to discriminant validity, MSIF global ratings shared markedly less variance with SAS II ratings centering on factors other than independent role functioning, such as social and family relationships, hobbies, and recreational activities.
As shown on table 4, with only one exception, less than 10 percent of shared variance is observed between MSIF ratings of independent role functioning and SAS II ratings of household and family relationships and social activities. This contrasts with shared variance ranging between 61 percent and 71 percent for ratings between the To examine the association and the amount of variance shared between variable sets generated by the two scales, we applied canonical correlation with redundancy analysis. For this purpose, the SAS II data set consisted of global ratings for role performance, social leisure, general adjustment, and household. The MSIF data set consisted of global ratings for work, education, and residential and for overall global. The relationship (amount of common variance) between the SAS II and MSIF variables was examined. The Wilks lambda statistic was used to test the statistical significance of the association.
The results of these analyses show that the two scales are not identical, in spite of the fact that their level of overlap is statistically significant In particular, canonical correlations indicated a significant overall association between the two scales (p < 0.001). However, redundancy analysis revealed that the MSIF carried a substantial proportion (56%) of variance that is not accounted for by the SASH.
Correlation of MSIF With Clinical and Illness History
Variables. Table 5 displays Spearman correlation coefficients between the MSEF global ratings and measures of IQ, psychopathology (BPRS), and illness history/course variables. Not surprisingly, MSIF ratings were modestly but significantly correlated with verbal-and full-scale IQ, and for MSIF education only, with performance IQ. Moderate relationships were also observed between MSIF ratings and BPRS total score. Among individual BPRS factor scores, both the anergia and thought disorder factors showed statistically significant relationships with MSIF global ratings. IQ and BPRS ratings shared between 5 and, in one instance, up to 34 percent of the variance with MSIF global ratings. This is consistent with previous reports relating ratings of disability with residual psychopathology (e.g., Strauss and Carpenter 1977) and cognitive functioning (e.g., Green 1996) . Future studies will be needed to examine, more specifically, relationships between MSIF ratings and cognitive operations, including those that contribute to IQ.
Age of illness onset was modestly related to education ratings, but not to work or residential global ratings. It is important to note that subjects not enrolled in any educational or skill development activity are not rated on this variable. Thus, correlations between onset characteristics and MSIF education ratings reflect variation in level of educational role position, support, and performance among only those engaged in an educational role. With the exception of education, there is a modest amount of shared variance between MSIF global ratings and time since most recent hospitalization, reflecting perhaps a trajectory of functional recovery subsequent to hospital discharge, or poorer functioning among subjects hospitalized more frequently. Longitudinal studies would be needed to determine which explanation is more correct, using the MSIF to study the functional recovery of patients following hospital discharge.
Construct Validity. With respect to the MSIF as a whole, construct validity was examined in two ways using Cronbach's alpha. In the first instance, we calculated the coefficient for a "scale" made up of the global ratings for each of the three environments. In the second instance, we calculated the standardized alpha coefficient to a "scale" made up of all nine individual ratings (RP, SU, and PE within each of three environments). In the first calculation, the standardized alpha coefficient was 0.72, and for the second, it was 0.67. Thus, in spite of being, by design, a scale that is multidimensional in nature, the MSIF subscores show a moderate level of internal consistency.
The MSIF was constructed so that RP, SU, and PE should be considered independently within each environment being rated. Nevertheless, in real-world environments, these three components rarely operate independently. Table 6 shows the Spearman correlation coefficient between these three components within work, education, and residential domains, respectively.
In each of the three environments, RP was uncorrelated to PE in that role. Within education, SU and PE were also uncorrelated, presumably because of truncated range on the PE ratings: those who have the greatest difficulty are unlikely to sustain this role at all. This is in contrast to the work and residential environments, where SU and PE were significantly correlated, sharing 27 percent and 19 percent of their variance, respectively. This most likely reflects the fact that, while added support is provided where performance difficulties occur, there are limits in the degree of impact mis support can have. RP and SU were modestly but significantly correlated in each of the three environments, sharing between 5 percent and 34 percent of the variance. This most likely reflects the degree to which subjects receiving greater supports take on less responsibility within that role, even with these supports, than those making minimal use of supports.
Discussion
The findings from this validation study demonstrate that within the environments of work, education, and residen- Note.-ns = nonsignificant; xx = auto-cofTBtation. tial functioning, disability in independent functioning can be reliably rated with the MSIF in a manner that distinguishes within each environment the patient's actual role responsibilities, the support received in meeting those responsibilities, and the quality of performance within that role. Good interrater agreement can be achieved using the MSIF. ICCs ranged from 0.74 to 1.00 (complete agreement) for the component ratings and from 0.91 to 0.98 for the global ratings.
The MSIF ratings appear to be valid indicators of community role functioning. Work RP ratings were correlated with salary and weekly hours worked. Work SU ratings discriminated subjects enrolled in supported and transitional employment from those working without professional supports. Education RP ratings discriminated those enrolled at least half-time from part-time students, and education SU ratings discriminated those in mainstream versus nonmainstream educational programs. Residential RP and SU ratings discriminated subjects living alone, with friends, or with a significant other from those living in a community residence or supported housing. These ratings also demonstrated that subjects living with family had lower role responsibilities and received less support than subjects living in a residential program. These findings suggested that in professionally operated residential programs, performance problems appear to be addressed by providing added support, consistent with recommended approaches in supported housing (Carling 1993) , while among those living widi family, performance problems tend to be addressed by reducing the patient's responsibilities within the residential setting. MSIF global ratings were closely correlated with comparable SAS II global ratings, thereby providing assurance of validity against a standard with which the field has extensive experience (Weissman et al. 1981) . With respect to discriminant validity, MSIF global ratings shared only modest variance with SAS II global ratings reflecting social and family relationships, hobbies, and recreational activities rather than instrumental roles. A redundancy analysis demonstrated that MSIF ratings do not duplicate the SAS II and provide additional information.
MSIF ratings shared between 5 and 20 percent of variance with IQ scores and ratings of psychopathology, a proportion of shared variance that is consistent with previous reports in the literature (Addington and Addington 1993) . With the exception of education ratings for those subjects enrolled in a school or training environment, MSIF ratings were not significantly correlated with age of illness onset or of first psychiatric treatment exposure. MSIF ratings were modestly correlated with time since most recent hospitalization.
MSIF subscores (RP, SU, and PE) within each environment shared only modest variance with one another, demonstrating that the three aspects of functioning contribute independently to the overall assessment of functioning. Standardized Cronbach's alpha coefficients also showed moderate internal consistency among the subcomponents, as would be expected from a multidimensional instrument One limitation in the standardization sample is that, because patient groups came from different sources having different diagnoses and possibly different levels of psychopathology, there may have been site differences with respect to some of the validation findings. Also, most of the subjects had a diagnosis within the schizophrenia spectrum. The MSIF is intended for use across the full range of psychiatric diagnoses. Studies are under way that include larger cohorts having bipolar and unipolar affective disorders, and conclusions about the utility of the MSIF for these samples must await those results. Another limitation is that with this sample, we did not examine the degree to which MSIF ratings are sensitive to change over time. Such a study will be critically important for determining whether the MSIF is sensitive enough to change to be useful in treatment trials.
While use of the MSIF requires a modest degree of training, a semi structured interview has been developed, and there are detailed anchors that minimize the training burden. Patient insight affects the reliability of all rating instruments that depend upon subject report, and the MSIF is no exception. The MSIF calls for verification and validation of information from second sources wherever possible. Reliable use of the MSIF probably depends more upon the interviewer's specific knowledge of the resources and programs the patient uses and his or her home environment than any features specific to the instrument The MSIF provides a rating of the patient's level of independent functioning in three distinct environmental domains and will not replace existing measures of social skill, activities of daily living, or appropriateness of social behavior. Indexes sampling content so different from the MSIF are unlikely to be highly correlated with measures of independent role functioning. This is supported by the findings of Brekke (1992) , who showed only modest convergent validity among three "outcome" instruments administered in the same sample of individuals with schizophrenia. Principal component and item content analysis demonstrated that work and residential role functioning appeared to constitute a different dimension than "social" functioning and psychiatric symptoms. Similarly, Dickerson et al. (2000) showed that activities of daily living, recreational and social activities, social skills, and frequency of family contact appeared to constitute a distinct dimension common to the three instruments they studied-one distinct from ratings of health, financial sufficiency, and social withdrawal.
An important consideration in designing the MSIF was to begin to address a major limitation with other functional disability scales, namely, that data from environments differing in available supports or tolerance for performance variation could not be reliably compared or combined (e.g., rural vs. urban samples, samples from developing vs. developed economies, and samples studied in similar settings but with differences in available supports at the time of rating). This is a problem that plagues multicenter trials examining the long-term cognitive and functional improvements associated with newer generation neuroleptics. In allowing for independent ratings of support and performance using the MSIF, we expect that data collected in a site having a rich array of formal supports for psychiatrically disabled individuals could be meaningfully studied alongside data from a different site having fewer support services. For example, given similar rates of disability in two subsamples, work RP ratings might be higher in an environment that is richer in supported employment services. An improvement in functional capacity occasioned by an effective treatment might be revealed in such a sample by a reduction of needed support but perhaps only a modest further increase in role position. On the other hand, in an environment lacking supported employment services, improved functioning might be manifested as improvements in RP with no discernable change in SU ratings. We know of no other instrument or method that has attempted to solve this problem. Nevertheless, the ability of the MSIF to accomplish this aim has not yet been determined and requires further study.
Functional disability ratings specifically focusing on instrumental roles, such as those provided by the MSIF, can provide useful information for the clinical investigation of the natural course of mental disorders, information that may prove to be critical in examining alternative phenotypes in genetic and pharmacological research. In addition, role functioning disability is an important outcome dimension for studies examining the effectiveness of new pharmacological and rehabilitative interventions, from both a clinical and an economic point of view. An effective instrument should provide measures of independent functioning free from the confound of clinical psychopathology and should separate out the contribution of RP, SU, and PE. By providing these features, the MSIF distinguishes itself from other available disability measures. Future studies will determine whether the MSIF is sufficiently sensitive to change to be useful for treatment research. In addition, future research will be needed to determine whether the independent ratings of RP, SU, and PE permit a more accurate analysis of the economics of disability than do currently available methods.
